Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 1:42 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 673–696 of 2,449 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Implant Clear all

Conditions: MRI Scans, Magnetic Resonance Imaging, Pacemaker, Implantable Cardioverter Defibrillator
Interventions: MRI Scan; Other
Lead sponsor: Lancaster General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 262 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: Lancaster, Pennsylvania

Conditions: Coronary Artery Disease
Interventions: Resolute Integrity stent; Device
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Anesthesia
Interventions: Blind Gastric Tube Placement; Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 166 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: Metastatic Lung Non-Small Cell Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8, Stage IVB Lung Cancer AJCC v8, Stage III Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8, Stage IIIB Lung Cancer AJCC v8, EGFR Mutation-Related Tumors
Interventions: EMB-01, Osimertinib; Drug
Lead sponsor: Shanghai EpimAb Biotherapeutics Co., Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 115 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 2
States / cities: Orange, California • Boston, Massachusetts

Conditions: Missing Tooth
Interventions: Platform-matched dental implant, Platform-switched dental implant; Procedure
Lead sponsor: University of Louisville; Other
Eligibility: 18 Years to 100 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Contraception
Interventions: Etonogestrel Implant; Device
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 1,076 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2021
U.S. locations: 2
States / cities: Indianapolis, Indiana • St Louis, Missouri

Conditions: Catheterization
Interventions: Peripherally Inserted Central Catheter Placement; Procedure
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 230 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Volume Loss in the Dorsum of the Hand
Interventions: Radiesse injectable implant and 2% lidocaine HCL; Device
Lead sponsor: Merz North America, Inc.; Industry
Eligibility: 22 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Vista, California

Conditions: Fecal Incontinence
Interventions: Bioengineered Internal Anal Sphincter; Biological
Lead sponsor: Cellf Bio LLC; Industry
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Visual Outcomes
Interventions: Acrysof ReSTOR multifocal IOL; Device
Lead sponsor: Alcon Research; Industry
Eligibility: 21 Years and older
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 1
States / cities: Fort Worth, Texas

Conditions: Cataract Surgery, Intraocular Lens Position, Refractive Outcomes After Cataract Surgery, Cataract
Interventions: Femtosecond Laser Capsulotomy - Small Size (4.6 mm), Femtosecond Laser Capsulotomy - Large Size (5.6 mm); Procedure
Lead sponsor: Twin Cities Eye Consultants; Other
Eligibility: 40 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Coon Rapids, Minnesota

Conditions: Heart Failure
Interventions: Thyroid hormone T3, Control Group; Drug · Other
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 2
States / cities: Atlanta, Georgia

Conditions: Paralysis, Unilateral, Vocal Cord
Interventions: APrevent® VOIS-Implant; Device
Lead sponsor: APrevent Biotech GmbH; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2026
U.S. locations: 4
States / cities: Phoenix, Arizona • Baltimore, Maryland • Cleveland, Ohio + 1 more

Conditions: Macular Telangiectasia Type 2
Interventions: NT-501 CNTF implant; Combination Product
Lead sponsor: Neurotech Pharmaceuticals; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 7
States / cities: Los Angeles, California • Washington D.C., District of Columbia • Miami, Florida + 4 more

Conditions: Fluoroscopy for Spine Surgery
Interventions: LessRay, Standard Fluoroscopy; Device
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Cardiac Surgical Procedures
Interventions: Not listed
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: New York, New York

Conditions: Diabetes Mellitus
Interventions: Continuous Glucose Monitoring System; Device
Lead sponsor: Senseonics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016
U.S. locations: 9
States / cities: Concord, California • Escondido, California • Walnut Creek, California + 5 more

Conditions: Pain
Interventions: Lidocaine, Normal Saline; Drug
Lead sponsor: Women's Health Care Clinic, Torrance, California; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: Torrance, California

Conditions: Bone Cement Implantation Syndrome
Interventions: Administration of general anaesthesia, Neuraxial Analgesia; Procedure
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Ischemic Optic Neuropathy/Optic Nerve Stroke
Interventions: NT-501 CNTF Implant; Drug
Lead sponsor: Jeffrey L Goldberg; Other
Eligibility: 40 Years and older
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Pancreatic Adenocarcinoma Non-resectable
Interventions: ACT Implantable Iontophoresis Chemotherapy Delivery Device with Gemcitabine (ACT-IOP-003); Combination Product
Lead sponsor: Continuity Biosciences, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: Ann Arbor, Michigan • Morgantown, West Virginia

Conditions: Dental Implants, TNF-alpha Inhibitors, Edentulism
Interventions: Placement of dental implants; Procedure
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Exudative Retinal Detachment and Uveal Melanoma
Interventions: Dexamethasone intravitreal implant; Drug
Lead sponsor: Ivana K. Kim; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Coronary Artery Disease
Interventions: Not listed
Lead sponsor: Holy Cross Hospital, Florida; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Fort Lauderdale, Florida

Search by objective public record fields.

Registry of Patients for MRI With Non-MRI Conditional Pacemakers and ICD Non-MRI Conditional Pacemakers and ICD

Optical Frequency Domain Imaging (OFDI) and Vascular Healing After Stent Placement

Blind Gastric Tube Placement: Incidence of Malposition Confirmed by Ultrasonography

EMB-01 in Combination With Osimertinib in Patients With EGFR Mutant Lung Cancer

The Effect of Platform-Matching Versus Platform-Switching Dental Implants on Peri-implant Hard and Soft Tissue Healing

Effectiveness of Prolonged Use of IUD/Implant for Contraception

Peripherally Inserted Central Catheter Placement by IV Team Nurses Using the Sonic Flashlight

Radiological Evaluation of Radiesse Implantation in the Hands

Implantation of BioSphincter TM for Treatment of Severe Passive Fecal Incontinence

Clinical Assessment of Visual Function With the Acrysof ReSTOR Multifocal IOL

The Effect of Capsulotomy Size on Effective Lens Position in Robotic Laser Cataract Surgery

Effects of Triiodothyronine (T3) in Ischemic Heart Failure

APrevent-VOIS-Implant-002 - a Two-Part, Open-Label, Non-Randomized Multicenter Study

Safety Study to Evaluate Bilateral CNTF Implants in Subjects With MacTel Type 2

A Prospective Study of LessRay Enhanced Versus Standard Fluoroscopic Visualization in Surgical Placement of Spinal Cord Stimulator

Placement of Permanent Pacemaker Study

Evaluation of the Accuracy of an Implanted Glucose Sensor

The Impact of Pain Scores on Intrauterine Lidocaine Versus Normal Saline Infusion at the Time of IUD Placement

Relationship Between Anesthetic Regimen and Bone Cement Implantation Syndrome (BCIS)

NT-501 CNTF Implant for Ischemic Optic Neuropathy: Safety, Neuroprotection and Neuroenhancement

A First-in-Human Study to Evaluate Implantable Iontophoresis Chemotherapy Delivery Device With Gemcitabine Once Weekly or Twice Weekly in Participants With Pancreatic Cancer

Dental Implant Healing With TNF-Alpha Inhibitors

Dexamethasone Implant for Retinal Detachment in Uveal Melanoma

The Holding Area LINQ (Reveal LINQ Insertable Cardiac Monitor) Trial is a Prospective, Non-randomized, Single Center Post-market Clinical Trial